Associated response in bone and lipids during hormone replacement therapy.

Area of Science:

• Endocrinology
• Bone Metabolism
• Cardiovascular Health

Background:

• Hormone replacement therapy (HRT) is used to manage menopausal symptoms.
• The effects of HRT on bone mineral density (BMD) and lipid profiles are well-documented.
• However, the relationship between BMD and lipid profile responses to HRT is not fully understood.

Purpose of the Study:

• To investigate the association between bone mineral density (BMD) response and atherogenic lipid profile response in postmenopausal women during hormone replacement therapy (HRT).

Main Methods:

• Exploratory, post-hoc analysis of a prospective, double-blind, placebo-controlled trial.
• 133 healthy postmenopausal women received various combinations of 17 beta-estradiol and gestodene or placebo for 3 years.
• BMD response measured as percentage change from baseline; lipid profile changes assessed to account for cyclic variations.

Main Results:

• Significant correlation found between increased BMD (spine, hip, forearm) and decreased serum low-density lipoprotein (LDL) and cholesterol.
• Decreased atherogenic lipids correlated significantly with bone resorption and formation markers.
• Identified that women with favorable BMD response also exhibited favorable lipid profile changes.

Conclusions:

• Favorable responses in BMD and lipid profiles during HRT occur in the same individuals.
• This association may be mediated by a common response to estradiol, potentially involving Follicle-Stimulating Hormone (FSH).
• Suggests common predictors for HRT response exist, warranting further investigation.